Literature DB >> 22582146

Developing genetically engineered mouse models to study tumor suppression.

Shunbin Xiong1, Jan Parker-Thornburg2, Guillermina Lozano1.   

Abstract

Since the late 1980s, the tools to generate mice with deletions of tumor suppressors have made it possible to study such deletions in the context of a whole animal. Deletion of some tumor suppressors results in viable mice while deletion of others yield embryo lethal phenotypes cementing the concept that genes that often go awry in cancer are also of developmental importance. More sophisticated mouse models were subsequently developed to delete a gene in a specific cell type at a specific time point. Additionally, incorporation of point mutations in a specific gene as observed in human tumors has also revealed their contributions to tumorigenesis. On the other hand, some models never develop cancer unless combined with other deletions suggesting a modifying role in tumorigenesis. This review will describe the technical aspects of generating these mice and provide examples of the outcomes obtained from alterations of different tumor suppressors.

Entities:  

Year:  2012        PMID: 22582146      PMCID: PMC3349200          DOI: 10.1002/9780470942390.mo110159

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  108 in total

1.  High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP.

Authors:  C I Rodríguez; F Buchholz; J Galloway; R Sequerra; J Kasper; R Ayala; A F Stewart; S M Dymecki
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Authors:  Shunbin Xiong; Vinod Pant; Young-Ah Suh; Carolyn S Van Pelt; Yongxing Wang; Yasmine A Valentin-Vega; Sean M Post; Guillermina Lozano
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

3.  TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.

Authors:  D M Li; H Sun
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

Review 4.  Studies on cryopreservation of embryos and gametes in mice.

Authors:  N Nakagata
Journal:  Exp Anim       Date:  1995-01

5.  NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.

Authors:  Qunying Lei; Jing Jiao; Li Xin; Chun-Ju Chang; Shunyou Wang; Jing Gao; Martin E Gleave; Owen N Witte; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

Authors:  Patrick W B Derksen; Xiaoling Liu; Francis Saridin; Hanneke van der Gulden; John Zevenhoven; Bastiaan Evers; Judy R van Beijnum; Arjan W Griffioen; Jacqueline Vink; Paul Krimpenfort; Johannes L Peterse; Robert D Cardiff; Anton Berns; Jos Jonkers
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

8.  Requirement for a functional Rb-1 gene in murine development.

Authors:  A R Clarke; E R Maandag; M van Roon; N M van der Lugt; M van der Valk; M L Hooper; A Berns; H te Riele
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

9.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.

Authors:  Xiaoling Liu; Henne Holstege; Hanneke van der Gulden; Marcelle Treur-Mulder; John Zevenhoven; Arno Velds; Ron M Kerkhoven; Martin H van Vliet; Lodewyk F A Wessels; Johannes L Peterse; Anton Berns; Jos Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.